Wood-Mitchell Amy, James Ian Andrew, Waterworth Anna, Swann Alan, Ballard Clive
Northumberland Tyne and Wear NHS Trust, Northumberland, UK.
Age Ageing. 2008 Sep;37(5):547-52. doi: 10.1093/ageing/afn135. Epub 2008 Jul 17.
despite evidence of limited efficacy, psychotropic medications are widely used as a first line treatment for those with behavioural and psychological symptoms of dementia (BPSD). Clearly various factors must be influencing their continued use; these are explored here.
to examine the process by which consultant old age psychiatrists prescribe for BPSD and explore the factors that influence their decisions.
a focus group generated initial questions for interviews with eight consultant old age psychiatrists, using a grounded theory methodology.
differences in how assessment information was utilised resulted in inconsistencies in choice of medication between psychiatrists. Psychiatrists felt pressured to prescribe, largely due to resource issues and lack of viable alternative treatments.
the ways in which psychiatrists prescribe for BPSD varies amongst clinicians. Guidelines do exist, but are difficult to implement in practice. Alternative non-pharmacological strategies are required, but as yet they are difficult to access and have a questionable evidence base.
尽管有证据表明疗效有限,但精神药物仍被广泛用作痴呆症行为和心理症状(BPSD)患者的一线治疗方法。显然,各种因素必定在影响它们的持续使用;本文对此进行探讨。
研究老年精神科顾问医生为BPSD开处方的过程,并探讨影响其决策的因素。
采用扎根理论方法,通过焦点小组讨论生成了用于采访八位老年精神科顾问医生的初始问题。
评估信息使用方式的差异导致精神科医生在药物选择上存在不一致。精神科医生感到有开处方的压力,主要是由于资源问题和缺乏可行的替代治疗方法。
精神科医生为BPSD开处方的方式在临床医生中各不相同。虽然存在指南,但在实践中难以实施。需要替代性的非药物策略,但目前难以获得且证据基础存疑。